LANTERN PHARMA INC. (LTRN) Net income 2019–2025
LANTERN PHARMA INC. (LTRN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$17.1MFY2025 · since FY2019: -$2.4M → -$17.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.1M | +17.6% |
| FY2024 | -$20.8M | -30.2% |
| FY2023 | -$16.0M | -11.9% |
| FY2022 | -$14.3M | -15.3% |
| FY2021 | -$12.4M | -109.3% |
| FY2020 | -$5.9M | -143.3% |
| FY2019 | -$2.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LTRN financial trends
LTRN RevenueLTRN Net marginLTRN Gross profitLTRN Gross marginLTRN Operating incomeLTRN Operating marginLTRN Operating cash flowLTRN Free cash flowLTRN Capital expendituresLTRN Return on equityLTRN Stock buybacksLTRN Dividends paidLTRN Total assetsLTRN Total liabilitiesLTRN Shareholders’ equityLTRN overview →